Topics
- New concepts to target RAS
- Therapeutic exploitation of DNA damage & repair pathways
- Targeting Transcription and MYC
- Autophagy & Ubiquitin-dependent signaling
- Tumor heterogeneity & cancer evolution
- Programmed cell death revisited
- Targeting the Vulnerabilities of Cancer
- Precision Oncology: from bench to bedside
Who should Attend
Cancer researchers from Germany and neighbouring countries.
AEK is the Division of Experimental Cancer Research (Abteilung Experimentelle Krebsforschung) of the German Cancer Society.
